Table 2 Clinical and hematological parameter distribution of the study subjects, at JUSH from July-September 2012

Age

16-70

32.1 ± 9.38

17-68

38.4 ± 10.04

20-67

36.9 ± 9.5

16-70

33.5 ± 10.3

16-70

34.7 ± 10

HIV dur. (months)

1-117

31 ± 27.6

1-96

29 ± 24.3

1-117

50.6 ± 25.7

1-90

18.9 ± 18.7

1-117

30 ± 26.3

ART dur. (months)

1-96

41 ± 25.8

1-76

36 ± 21.9

1-96

39 ± 24.5

–

–

1-96

39.11 ± 24.46

CD4 count

5-1377

406 ± 232.6

36-1421

343 ± 199.07

5-1314

429.2 ± 337.5

7.6-16.9

352 ± 207

5-1421

380 ± 221

Hemoglobin

4.3-15.6

11.9 ± 1.65

7.8-18.6

12.6 ± 2.1

4.3-18.6

12.6 ± 1.85

2.4-13

11.9 ± 1.8

4.3-18.6

12.2 ± 1.9

WBC × 10³

1.8-13.0

6.007 ± 1.92

2.3-11.6

6.069 ± 1.78

1.8-12.5

6.28 ± 2

1.2-9.88

5.89 ± 1.76

1.8-13

6.03 ± 1.86

ANC × 10³

1.062-9.88

3.549 ± 1.56

.920-8.424

3.530 ± 1.39

0.92-9.5

3.76 ± 1.7

0.35-5.05

3.42 ± 1.3

0.92-9.88

3.54 ± 1.48

TLC × 10³

0.349-5.05

1.854 ± 0.76

.543-4.325

1.854 ± 0.706

0.57-4.3

1.9 ± 0.7

13-987

1.82 ± 0.75

0.349-5.05

1.85 ± 0.74

Platelet count × 10³

62.0-987.0

296.769 ± 135.22

13-890

276.953 ± 149.89

73-750

290.3 ± 111.5

21-1421

287.6 ± 156.2

13-987

288.59 ± 141.59